Global Latanoprost Market Growth 2025-2031

The global Latanoprost market size is predicted to grow from US$ 1404 million in 2025 to US$ 1607 million in 2031; it is expected to grow at a CAGR of 2.3% from 2025 to 2031.

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (e.g., ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

In the report, one unit refers to one bottle.

Pfizer, Mylan and Novartis are the leaders of the Latanoprost industry, which take about 57% market share. North America is the major region of the global market, which takes about 35% market share.

LP Information, Inc. (LPI) ' newest research report, the “Latanoprost Industry Forecast” looks at past sales and reviews total world Latanoprost sales in 2024, providing a comprehensive analysis by region and market sector of projected Latanoprost sales for 2025 through 2031. With Latanoprost sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Latanoprost industry.

This Insight Report provides a comprehensive analysis of the global Latanoprost landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Latanoprost portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Latanoprost market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Latanoprost and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Latanoprost.

This report presents a comprehensive overview, market shares, and growth opportunities of Latanoprost market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Brand Drug
Generic Drug

Segmentation by Application:
Open-angle Glaucoma
Close-angle Glaucoma

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu

Key Questions Addressed in this Report

What is the 10-year outlook for the global Latanoprost market?

What factors are driving Latanoprost market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Latanoprost market opportunities vary by end market size?

How does Latanoprost break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.